The 2024 program will be available in early March 2024. Please review our dynamic sessions from the 2023 BIO International Convention in Boston to see examples of topics and speakers.

BIO International Convention
Date
  • Show All
Time
  • Show All
  • Show All
  • Show All
Company Type
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Sessions
BIO International Convention
Jump to Day
Results
Time
Monday, June 5
12:30 PM - 12:45 PM
QBiotics is a public unlisted Australian life sciences company that discovers and develops new…
Session Room 103
12:45 PM - 1:00 PM
Inimmune is a fast-moving innovative biotechnology company focused on the discovery and development…
Session Room 103
Starpax has developed a never before seen technology that guides in 3D Magnetodrones™ in tumors…
Session Room 104C
1:00 PM - 1:15 PM
Glycostem is focused on the development of first and second generation stem cell-derived Natural…
Session Room 103
1:15 PM - 1:30 PM
Biocytogen is a global biotechnology company that drives the research and development of novel…
Session Room 103
We are a clinical-stage biotechnology company dedicated to the discovery and development of…
Session Room 104C
1:30 PM - 1:45 PM
Atreca is a clinical-stage biotech company inverting the traditional approach to cancer drug…
Session Room 103
1:45 PM - 2:00 PM
AVEO Oncology, an LG Chem Company, is a commercial stage, oncology-focused biopharmaceutical…
Session Room 103
2:00 PM - 2:15 PM
PharmAbcine Inc. is a clinical stage public company developing next generation antibody…
Session Room 103
2:15 PM - 2:30 PM
We are a clinical-stage biopharmaceutical company focused on developing novel synthetic lethality…
Session Room 104C
Privo Technologies, Inc. (Privo) is a phase 3 clinical-stage biopharmaceutical company committed to…
Session Room 103
2:30 PM - 2:45 PM
One carbon therapeutics is developing innovative therapeutics for oncology indications with high…
Session Room 103
2:45 PM - 3:00 PM
Predictive Oncology is a knowledge-driven company disrupting the oncology drug discovery paradigm…
Session Room 103
4:00 PM - 4:15 PM
HAII is one of the most innovative digital therapeutics companies in South Korea. HAII was founded…
Session Room 104A
Tuesday, June 6
11:00 AM - 1:00 PM
We, ARCE Therapeutics, Inc., specialize in developing first and best-in-class gene-modified…
North Lobby
Ardan Pharma is an academic spin off company, investigating one guilty molecule of checkpoint…
North Lobby
Asgard Therapeutics is a Swedish private biotech company advancing cancer immunotherapies by…
North Lobby
Gilboa is a preclinical-stage biopharmaceutical company, co-located in Boston and Israel, that is…
North Lobby
Saros Therapeutics is developing an innate immune activation technology for oncology. While…
North Lobby
12:15 PM - 12:30 PM
AIVITA Biomedical is a biotechnology company developing personalized vaccines for the prevention of…
Session Room 103
2:00 PM - 4:00 PM
Anticipate Bioscience is built on 5 years of world class medicinal chemistry by a veteran oncology…
North Lobby
T-E Meds, Inc. is a subsidiary company of T-E Pharma Holding which focuses on antibody-drug…
North Lobby
2:00 PM - 2:15 PM
Novasenta is focused on the discovery of novel therapeutic targets to develop innovative and…
Session Room 103
2:15 PM - 2:30 PM
HTG is a platform-based drug discovery company using proprietary transcriptome-wide profiling and…
Session Room 103
2:30 PM - 2:45 PM
Servier is an independent pharmaceutical company committed to therapeutic progress to serve patient…
Session Room 104B
Theranostec develops precision nanomedicines that significantly improve both the delivery and…
Session Room 103
2:45 PM - 3:00 PM
NuvOx is a Phase IIb platform biotech company. Focusing on reversing hypoxia (lack of oxygen), the…
Session Room 103
3:00 PM - 3:15 PM
Osmol is a spin-out of Yale University developing a novel treatment, OSM-0205, to prevent…
Session Room 103
3:15 PM - 3:30 PM
As NCI SBIR Investor Initiative Awardee, we are leveraging a cutting-edge approach using…
Session Room 103
3:30 PM - 3:45 PM
SIRPant Immunotherapeutics Inc. is focused on the development of novel autologous macrophage cell…
Session Room 103
3:45 PM - 4:00 PM
Pharos iBio is a clinical stage biotech company that develops novel drug for rare and refractory…
Session Room 103
4:00 PM - 4:15 PM
Hello, we are a startup company established in National Cancer Center (NCC), Korea developing anti…
Session Room 103
4:15 PM - 4:30 PM
Panavance Therapeutics Inc. is a privately held, clinical-stage pharmaceutical company developing a…
Session Room 103
4:30 PM - 4:45 PM
Kernal Bio is a venture-backed biotech company developing mRNA 2.0 immunotherapies. Kernal Bio…
Session Room 103
4:45 PM - 5:00 PM
Clinical stage company focusing on Radiopharmaceutical Imaging and Therapies in Oncology
Session Room 103
Wednesday, June 7
12:00 PM - 12:15 PM
Concarlo Therapeutics is a preclinical-stage oncology company developing transformative…
Session Room 104A
Immuneering is a clinical-stage oncology company developing medicines for broad populations of…
Session Room 103
12:15 PM - 12:30 PM
Breakpoint Therapeutics GmbH is a pre-clinical stage company dedicated to the discovery and…
Session Room 104A
OncoHost is a commercial-stage precision oncology company headquartered in Binyamina, Israel, and…
Session Room 104B
1:45 PM - 2:00 PM
Enterome is a clinical stage company developing off-the-shelf, transformational cancer treatments…
Session Room 104A
2:00 PM - 4:00 PM
ARIZ Precision Medicine (pronounced “Arise”) is developing first in class cancer therapeutics based…
North Lobby
CorriXR Therapeutics is an oncology-focused biotherapeutics development company enabled by a novel…
North Lobby
FAKnostics is a dynamic pharmaceutical and diagnostics company, developing next generation drugs…
North Lobby
Grannus Therapeutics is a pre-clinical platform company focused on developing and commercializing…
North Lobby
Guardian Bio is a cancer therapeutics platform creating the next generation of cell therapies to…
North Lobby
March Biosciences, Inc is a clinical-stage cell therapy company with a mission to transform patient…
North Lobby
OmniCyte is a preclinical Immunology company. Our therapeutics are developed on our proprietary,…
North Lobby
2:00 PM - 2:15 PM
Galapagos is a fully integrated biotechnology company focused on discovering, developing and…
Session Room 104A
2:15 PM - 2:30 PM
MAIA Biotechnology, Inc. is a targeted therapy, immune-oncology company, focused on development of…
Session Room 104A
2:30 PM - 2:45 PM
Amgen is one of the world’s leading biotechnology companies. Amgen is a values-based company,…
Session Room 104B
Sensei Biotherapeutics (NASDAQ: SNSE) is an immuno-oncology company focused on the discovery and…
Session Room 104A
2:45 PM - 3:00 PM
IMUNON is a fully integrated, clinical-stage biotechnology company focused on advancing a portfolio…
Session Room 104A
3:00 PM - 3:15 PM
Affivant is a Basel, Switzerland based biotech company developing innate immune cell engagers for…
Session Room 104B
Lokon Pharma is a privately owned, Swedish biotech company developing immunostimulatory gene…
Session Room 104A
3:15 PM - 3:30 PM
Rakuten Medical, Inc. is a global biotechnology company developing and commercializing precision,…
Session Room 104A
3:30 PM - 3:45 PM
We are a clinical-stage biopharmaceutical company focused on the development of GP2, an…
Session Room 104A
3:45 PM - 4:00 PM
Kintara Therapeutics is a clinical stage drug development company with a focus on the development…
Session Room 104A
4:00 PM - 4:15 PM
Affini-T is unlocking the power of T cells and targeting core oncogenic drivers to develop…
Session Room 104B
With more than 65 years of experience in delivering life-changing science, Lantheus is committed to…
Session Room 104A
4:15 PM - 4:30 PM
Arpeggio makes medicine to alter gene expression and fight drug resistance in cancer. We do this by…
Session Room 104B
Genesis Therapeutics has created the industry's most advanced molecular AI platform by combining…
Session Room 104C
Like real-time traffic data revolutionized how we drive, Pepper Bio, the world’s first transomics…
Session Room 104A
4:30 PM - 4:45 PM
At Avstera, our primary focus is to address the significant unmet need of cancer patients failing…
Session Room 104B
CancerFree Biotech is a start-up company dedicated to personalized treatment of cancer. We…
Session Room 104A
4:45 PM - 5:00 PM
Accession Therapeutics is developing a new generation of immunotherapies for solid tumors. …
Session Room 104B
NeoImmuneTech (NIT) is a T-cell Centric IO Company and the Global Leader in Interleukin (IL-7). At…
Session Room 104A
Thursday, June 8
10:30 AM - 10:45 AM
Modulus Discovery, Inc., is a pre-clinical stage biotechnology company with a cutting-edge…
Session Room 103
11:00 AM - 11:15 AM
ITabMed Ltd. is a clinical-stage biotech company developing immunotherapy antibodies (ITAbTM) to…
Session Room 103
11:15 AM - 11:30 AM
KaliVir Immunotherapeutics is a private biotechnology company dedicated to developing systemically…
Session Room 103
11:30 AM - 11:45 AM
Phanes is a clinical stage biotech focused on innovative drug discovery and development in oncology…
Session Room 103
12:00 PM - 12:15 PM
FivepHusion is an advanced clinical stage biotech company developing Deflexifol™, a novel enhanced…
Session Room 103
12:30 PM - 12:45 PM
Henlius is a global biopharmaceutical company with the vision to offer high-quality, affordable,…
Session Room 103
12:45 PM - 1:00 PM
Co-founded by Professor Junying Yuan and Professor Jidong Zhu, two leading scientists in cell death…
Session Room 103